3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
33
Lymphoma
17
Lymphoma, Large-Cell, Anaplastic
15
Hematologic Diseases
13
Lymphoma, Non-Hodgkin
10
Recurrence
9
Lymphoma, T-Cell
7
Lymphoma, T-Cell, Peripheral
6
Lymphoma, Large B-Cell, Diffuse
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, B-Cell
4
Neoplasms
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphatic Diseases
3
Leukemia
3
Immunoblastic Lymphadenopathy
3
Sezary Syndrome
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms by Histologic Type
2
Lymphoproliferative Disorders
2
Lymphoma, Extranodal NK-T-Cell
2
Leukemia, Myeloid, Acute
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Enteropathy-Associated T-Cell Lymphoma
2
Waldenstrom Macroglobulinemia
1
Testicular Neoplasms
1
Nonseminomatous germ cell tumor
1
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
Brentuximab Vedotin
×
Clear all
No trials found.